0001144204-13-014648.txt : 20130312 0001144204-13-014648.hdr.sgml : 20130312 20130312183027 ACCESSION NUMBER: 0001144204-13-014648 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20130308 FILED AS OF DATE: 20130312 DATE AS OF CHANGE: 20130312 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Akirov Alfred CENTRAL INDEX KEY: 0001434514 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33357 FILM NUMBER: 13685545 MAIL ADDRESS: STREET 1: ALROV TOWER STREET 2: 46 ROTHSCHILD BLVD CITY: TEL AVIV STATE: L3 ZIP: 66883 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Protalix BioTherapeutics, Inc. CENTRAL INDEX KEY: 0001006281 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 650643773 STATE OF INCORPORATION: FL FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2 SNUNIT ST STREET 2: SCIENCE PARK, POB 455 CITY: CARMIEL STATE: L3 ZIP: 20100 BUSINESS PHONE: 972-4-988-9488 MAIL ADDRESS: STREET 1: 2 SNUNIT ST STREET 2: SCIENCE PARK, POB 455 CITY: CARMIEL STATE: L3 ZIP: 20100 FORMER COMPANY: FORMER CONFORMED NAME: ORTHODONTIX INC DATE OF NAME CHANGE: 19980422 FORMER COMPANY: FORMER CONFORMED NAME: EMBASSY ACQUISITION CORP DATE OF NAME CHANGE: 19960124 4 1 v337975_4.xml OWNERSHIP DOCUMENT X0306 4 2013-03-08 0 0001006281 Protalix BioTherapeutics, Inc. PLX 0001434514 Akirov Alfred C/O PROTALIX BIOTHERAPEUTICS, INC. 2 SNUNIT STREET SCIENCE PARK, POB 455 CARMIEL L3 20100 ISRAEL 1 0 0 0 Common Stock 2013-03-08 4 S 0 10000 5.82 D 5062911 I By Corporation Common Stock 2013-03-08 4 S 0 2500 5.91 D 5060411 I By Corporation Common Stock 2013-03-08 4 S 0 2500 5.92 D 5057911 I By Corporation Common Stock 2013-03-08 4 S 0 1898 5.95 D 5056013 I By Corporation Common Stock 2013-03-11 4 S 0 300 5.79 D 5055713 I By Corporation Common Stock 2013-03-11 4 S 0 3000 5.75 D 5052713 I By Corporation Common Stock 2013-03-11 4 S 0 10000 5.72 D 5042713 I By Corporation Common Stock 2013-03-11 4 S 0 5000 5.71 D 5037711 I By Corporation All sales reported on this Form 4 were made by Alrov (Israel) Ltd.("Alrov Israel") and the column in Table 1 disclosing the amount of securities beneficially owned following the reported transactions includes 686,046 shares of our common stock held by Technorov Holdings (1993) Ltd. ("Technorov"). Alrov Israel owns 100% of Al-Rov Technologies Holdings LTD, the holder of 80% of Technorov. The reporting person is the Chairman of Alrov Israel and the Chief Executive Officer of Technorov, and has the power to control their respective investment decisions. Alrov Israel is an Israeli publicly-traded company that is listed on the Tel Aviv Stock Exchange. Mr. Akirov disclaims beneficial ownership of the securities of the Issuer held by Alrov Israel and Technorov, except to the extent of his proportional pecuniary interest therein. /s/ Yossi Maimon, POA 2013-03-12